Evaxion Biotech A/S

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Evaxion Biotech A/S had 18.44M in cash and cash equivalents.

Evaxion Biotech A/S reported 11.37M in total liabilities as of the latest reported quarter, including 4.26M in current liabilities and 7.11M in non-current liabilities.

As of the latest reported quarter, Evaxion Biotech A/S's total assets were 28.41M, consisting of 24.90M in current assets and 3.51M in non-current assets.

Evaxion Biotech A/S reported 17.04M in total shareholders' equity as of the latest reported quarter.